ORIGINAL RESEARCH
Published on 13 Sep 2022
Risk of major adverse limb events in patients with type 2 diabetes mellitus receiving sodium glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A population-based retrospective cohort study
doi 10.3389/fphar.2022.869804
- 1,701 views
- 2 citations